Product Information
BRIELLYN 0.4 MG-0.035 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3471 per EA under NDC 68462031629. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 22, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462031629
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA090538FDA Approved
3/22/2011
TE Code
AB
On Market Since
3/23/2011
Price Statistics
The NADAC for BRIELLYN 0.4 MG-0.035 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 56.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3471 per EA |
|---|---|
| All-time high | $0.9162 (Feb 11, 2015) |
| All-time low | $0.2566 (Nov 20, 2024) |
| 52-week high | $0.3471 |
| 52-week low | $0.2982 |
| Median price | $0.5155 |
| Average price | $0.5319 |
| Largest weekly change | +60.7% (May 20, 2020) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BRIELLYN 0.4 MG-0.035 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BRIELLYN 0.4 MG-0.035 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3471 per EA (NDC 68462031629), effective Aug 19, 2026.
How has the price of BRIELLYN 0.4 MG-0.035 MG TAB changed over time?
Over the history we have for it, the NADAC for BRIELLYN 0.4 MG-0.035 MG TAB has declined 56.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BRIELLYN 0.4 MG-0.035 MG TAB?
Since Nov 28, 2013, the NADAC for BRIELLYN 0.4 MG-0.035 MG TAB has ranged from a low of $0.2566 (Nov 20, 2024) to a high of $0.9162 (Feb 11, 2015), with a median of $0.5155 per EA.
Are there cheaper alternatives to BRIELLYN 0.4 MG-0.035 MG TAB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYLIA 1-35 28 TABLET, is $0.2116 per EA — about 39% below BRIELLYN 0.4 MG-0.035 MG TAB.
Who manufactures BRIELLYN 0.4 MG-0.035 MG TAB?
BRIELLYN 0.4 MG-0.035 MG TAB (NDC 68462031629) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.